|Articles|July 1, 2006

LCGC Supplements

  • Special Issues-07-01-2006
  • Volume 0
  • Issue 0

Party's Over

Pharmaceutical marketing and sales folks are now contending within creased government scrutiny of direct-to-consumer advertising and pharma-doctor relationships.
External Link - article-416326.pdf

Articles in this issue

over 19 years ago

Analytical Instrument Qualification

over 19 years ago

GMP and Phase I Clinical Trials: Streamlining the Critical Path?

over 19 years ago

Team Effort

over 19 years ago

Rated PG: Pharmaceutical Guidance Suggested

over 19 years ago

European Clinical Trial Regulations Undergo a Slow Revolution

over 19 years ago

A Practical and Cost-Effective Risk Assessment for the Validation of Commercial Laboratory Computerized Systems

over 19 years ago

Moving Biotech Products from CBER to CDER: A Work in Progress

over 19 years ago

FDA Video Interview Conducted by Jill Wechsler, Washington Bureau Chief

over 19 years ago

New Climate

over 19 years ago

2006: A Regulatory Odyssey

Newsletter

Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.

Subscribe Now!

Related Content